Genomic Characterization of NSCLC in African Americans: A Step Toward "Race-Aware" Precision Medicine.
作者信息
Mamdani Hirva, Schwartz Ann G
机构信息
Department of Oncology, Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
Department of Oncology, Wayne State University School of Medicine and the Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.
出版信息
J Thorac Oncol. 2020 Dec;15(12):1800-1802. doi: 10.1016/j.jtho.2020.10.009.
Abstract
摘要
相似文献
1
Genomic Characterization of NSCLC in African Americans: A Step Toward "Race-Aware" Precision Medicine.非裔美国人非小细胞肺癌的基因组特征：迈向“种族意识”精准医学的一步。
J Thorac Oncol. 2020 Dec;15(12):1800-1802. doi: 10.1016/j.jtho.2020.10.009.
2
Role of Precision Oncology in Type II Endometrial and Prostate Cancers in the African Population: Global Cancer Genomics Disparities.精准肿瘤学在非洲人群 II 型子宫内膜癌和前列腺癌中的作用：全球癌症基因组学差异。
Int J Mol Sci. 2022 Jan 6;23(2):628. doi: 10.3390/ijms23020628.
3
Genomic Characterization of Non-Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel Sequencing.通过靶向大规模平行测序对非裔美国人非小细胞肺癌进行基因组特征分析。
J Clin Oncol. 2015 Jun 10;33(17):1966-73. doi: 10.1200/JCO.2014.59.2444. Epub 2015 Apr 27.
4
Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.非小细胞肺癌中非裔美国人表皮生长因子受体突变的频率和类型。
J Thorac Oncol. 2011 Mar;6(3):627-30. doi: 10.1097/JTO.0b013e31820a0ec0.
5
Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.多中心比较 17 基因基因组前列腺评分作为预测非洲裔美国人和高加索裔美国男性临床局限性前列腺癌结局的指标。
J Urol. 2021 Apr;205(4):1047-1054. doi: 10.1097/JU.0000000000001484. Epub 2020 Dec 1.
6
Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials.破坏精准医学努力：乳腺癌临床试验中少数民族代表性不足的障碍。
Breast Cancer Res Treat. 2021 Jun;187(3):605-611. doi: 10.1007/s10549-021-06264-x. Epub 2021 Jun 2.
7
Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.非小细胞肺癌中非洲裔美国患者的 EGFR 通路的遗传异常。
J Clin Oncol. 2009 Nov 20;27(33):5620-6. doi: 10.1200/JCO.2009.23.1431. Epub 2009 Sep 28.
8
Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.非裔美国人和高加索人三阴性乳腺癌突变图谱的差异。
Breast Cancer Res Treat. 2017 Feb;161(3):491-499. doi: 10.1007/s10549-016-4062-y. Epub 2016 Dec 3.
9
Admixture mapping of lung cancer in 1812 African-Americans.1812 名非裔美国人肺癌的混合映射分析。
Carcinogenesis. 2011 Mar;32(3):312-7. doi: 10.1093/carcin/bgq252. Epub 2010 Nov 29.
10
Black Is Diverse: The Untapped Beauty and Benefit of Cancer Genomics and Precision Medicine.黑人具有多样性：癌症基因组学与精准医学中未被发掘的美与益处。
JCO Oncol Pract. 2021 May;17(5):279-283. doi: 10.1200/OP.21.00236.
引用本文的文献
1
Unique fusion is associated with marked response to crizotinib in lung adenocarcinoma.独特融合与肺腺癌对克唑替尼的显著反应相关。
SAGE Open Med Case Rep. 2022 May 21;10:2050313X221100407. doi: 10.1177/2050313X221100407. eCollection 2022.
本文引用的文献
1
Whole-Exome Profiling of NSCLC Among African Americans.非裔美国人的非小细胞肺癌全外显子组分析。
J Thorac Oncol. 2020 Dec;15(12):1880-1892. doi: 10.1016/j.jtho.2020.08.029. Epub 2020 Sep 12.
2
STK11 (LKB1) missense somatic mutant isoforms promote tumor growth, motility and inflammation.STK11（LKB1）错义体细胞突变体同工型促进肿瘤生长、迁移和炎症。
Commun Biol. 2020 Jul 9;3(1):366. doi: 10.1038/s42003-020-1092-0.
3
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.KEYNOTE-189 更新分析：帕博利珠单抗或安慰剂联合培美曲塞和铂类化疗用于未经治疗的转移性非鳞状非小细胞肺癌。
J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.
4
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.纳武利尤单抗联合伊匹单抗治疗晚期非小细胞肺癌。
N Engl J Med. 2019 Nov 21;381(21):2020-2031. doi: 10.1056/NEJMoa1910231. Epub 2019 Sep 28.
5
Enrollment of Racial Minorities in Clinical Trials: Old Problem Assumes New Urgency in the Age of Immunotherapy.临床试验中少数族裔的招募：在免疫治疗时代，老问题有了新的紧迫性。
Am Soc Clin Oncol Educ Book. 2019 Jan;39:3-10. doi: 10.1200/EDBK_100021. Epub 2019 May 17.
6
Racial/Ethnic Differences in Lung Cancer Incidence in the Multiethnic Cohort Study: An Update.多民族队列研究中肺癌发病率的种族/民族差异：最新进展。
J Natl Cancer Inst. 2019 Aug 1;111(8):811-819. doi: 10.1093/jnci/djy206.
7
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.KEYNOTE-024 更新分析：PD-L1 肿瘤比例评分≥50%的晚期非小细胞肺癌的帕博利珠单抗对比铂类化疗
J Clin Oncol. 2019 Mar 1;37(7):537-546. doi: 10.1200/JCO.18.00149. Epub 2019 Jan 8.
8
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.帕博利珠单抗联合化疗用于鳞状非小细胞肺癌。
N Engl J Med. 2018 Nov 22;379(21):2040-2051. doi: 10.1056/NEJMoa1810865. Epub 2018 Sep 25.
9
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.- 突变与 PD-1 抑制剂耐药在 - 突变型肺腺癌中的研究进展
Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.
10
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2).具有可靶向突变的肺腺癌患者中吸烟和 TP53 突变的影响-肺癌突变联盟（LCMC2）。
Clin Cancer Res. 2018 Mar 1;24(5):1038-1047. doi: 10.1158/1078-0432.CCR-17-2289. Epub 2017 Dec 7.
Zotero 插件